Stiles Financial Services Inc United Therapeutics Corp Transaction History

Stiles Financial Services Inc

  • $282 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 08, 2023
SELL
$211.82 - $248.24 $4,236 - $4,964
-20 Reduced 1.45%
1,358 $306,000
Q3 2022

Nov 02, 2022
BUY
$203.3 - $244.17 $35,577 - $42,729
175 Added 14.55%
1,378 $289,000
Q4 2021

Feb 09, 2022
BUY
$184.32 - $216.08 $221,736 - $259,944
1,203 New
1,203 $260,000

Others Institutions Holding UTHR

# of Institutions
679
Shares Held
42.1M
Call Options Held
194K
Put Options Held
295K
View Full List

About UNITED THERAPEUTICS Corp

UTHR Quotes by TradingView
  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.9B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Stiles Financial Services Inc Portfolio

Follow Stiles Financial Services Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stiles Financial Services Inc, based on Form 13F filings with the SEC.

News

Stay updated on Stiles Financial Services Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email